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Problem
Inflammation and infection play a major role in preterm birth. The pur-
pose of this study was to (i) determine the prevalence and clinical signif-
icance of sterile intra-amniotic inflammation and (ii) examine the
relationship between amniotic fluid (AF) concentrations of high mobility
group box-1 (HMGB1) and the interval from amniocentesis to delivery
in patients with sterile intra-amniotic inflammation.
Method of study
AF samples obtained from 135 women with preterm labor and intact
membranes were analyzed using cultivation techniques as well as
broad-range PCR and mass spectrometry (PCR/ESI-MS). Sterile intra-
amniotic inflammation was defined when patients with negative AF cul-
tures and without evidence of microbial footprints had intra-amniotic
inflammation (AF interleukin-6 ≥ 2.6 ng/mL).
Results
(i) The frequency of sterile intra-amniotic inflammation was signifi-
cantly greater than that of microbial-associated intra-amniotic inflam-
mation [26% (35/135) versus 11% (15/135); (P = 0.005)], (ii) patients
with sterile intra-amniotic inflammation delivered at comparable gesta-
tional ages had similar rates of acute placental inflammation and
adverse neonatal outcomes as patients with microbial-associated intra-
amniotic inflammation, and (iii) patients with sterile intra-amniotic
inflammation and high AF concentrations of HMGB1 (≥8.55 ng/mL)
delivered earlier than those with low AF concentrations of HMGB1
(P = 0.02).
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Conclusion
(i) Sterile intra-amniotic inflammation is more frequent than microbial-
associated intra-amniotic inflammation, and (ii) we propose that danger
signals participate in sterile intra-amniotic inflammation in the setting of
preterm labor.
Introduction
Preterm labor is the leading cause of perinatal mor-
bidity and mortality worldwide.1–6 Two-thirds of
preterm deliveries occur after the spontaneous onset
of preterm labor, with either intact or ruptured
membranes.7–11 Preterm labor is one of the great
obstetrical syndromes,11–15 in which the presenting
symptoms and signs largely represent activation of
the common pathway of parturition [i.e., increased
uterine contractility,16–26 cervical remodeling,27–39
and membrane/decidual activation40–55]. Activation
of the common pathway of parturition can be the
result of multiple pathological processes.11,14 Intra-
amniotic inflammation due to microbial invasion of
the amniotic cavity (MIAC) is an important cause of
spontaneous preterm delivery,56–80 and the molecu-
lar mechanisms responsible for parturition in this
scenario have been extensively studied.81–119
Intra-amniotic inflammation can be due to micro-
organisms (bacteria, parasites, or viruses) or to other
mechanisms of disease in which necrosis or cellular
stress induces a release of mediators which activate
the innate immune system.120–123 We have used the
term ‘sterile intra-amniotic inflammation’ to refer to
an inflammatory process in which microorganisms
cannot be detected.124–130 The precise stimuli for ster-
ile intra-amniotic inflammation in patients with pre-
term labor and intact membranes have not been
identified. One possibility is that damage-associated
molecular patterns (DAMPs) are responsible for
this inflammatory process, as well as in a subset of
patients with clinical chorioamnionitis at
term.127,129,131 Several alarmins, including interleukin
(IL)-1a,89,132 S100 calcium binding protein B (S1
00B),125 high mobility group box-1 (HMGB1),129,131
and heat-shock proteins,127 are increased in the amni-
otic fluid (AF) of women with intra-amniotic inflam-
mation.126 HMGB1 is a prototypic alarmin,133–142 and
increased concentrations of this alarmin may reflect
engagement of DAMPs-induced inflammation.141–151
HMGB1 plays a key role in mediating inflammation
in response to microorganisms, as well as sterile
inflammation due to cell injury. HMGB1 is secreted
actively during microbial invasion or cellular stress
and passively by damage of cellular integrity.152–154 In
this study, we sought to (i) determine the frequency
and clinical significance of sterile intra-amniotic
inflammation and (ii) examine the relationship
between the AF concentrations of HMGB1 and the
interval from amniocentesis to delivery in patients
with sterile intra-amniotic inflammation.
Materials and methods
Study population
A prospective cohort of women with singleton preg-
nancies who presented with spontaneous preterm
labor and intact membranes was selected from the
clinical database and Bank of Biological Samples
maintained by Wayne State University, the Detroit
Medical Center, and the Perinatology Research
Branch of the Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development
(NICHD) if they met the following criteria: (i) had an
amniocentesis (transabdominal) performed between
20 and 35 weeks of gestation prior to the rupture of
the chorioamniotic membranes, (ii) absence of chro-
mosomal or structural fetal anomalies, and (iii) the
pregnancy outcome was known. This population rep-
resents a subset of that included in a study previ-
ously reported in this journal130 focusing on the use
of molecular microbiologic techniques. Women with
an insufficient volume of AF required for the deter-
mination of HMGB1 were excluded from this analy-
sis [5% (7/142)]. Each patient provided written
informed consent, and the use of biological speci-
mens and clinical data for research purposes was
approved by the Institutional Review Boards of
NICHD and Wayne State University.
Clinical Definitions
Preterm labor was diagnosed by the presence of reg-
ular uterine contractions (at least 3 in 30 min) and
documented cervical changes in patients with a
gestational age between 20 and 36 6/7 weeks.
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Preterm delivery was defined as birth prior to the
37th week of gestation. MIAC was defined as either
a positive culture for bacteria in AF or the detection
of microbial footprints for either viruses or bacteria,
using polymerase chain reaction (PCR) coupled with
electrospray ionization mass spectrometry (ESI-MS)
(Ibis technology - Athogen, Carlsbad, CA, USA).
Intra-amniotic inflammation was diagnosed when
AF IL-6 concentration was ≥2.6 ng/mL.72,155 Micro-
bial-associated intra-amniotic inflammation was
defined as the presence of MIAC with intra-amniotic
inflammation. Sterile intra-amniotic inflammation
was diagnosed when the AF IL-6 concentration was
≥2.6 ng/mL, and there was no evidence of microbial
footprints for viruses or bacteria (negative AF culture
and no detection of microbial footprints using PCR/
ESI-MS).
Composite neonatal morbidity was defined as the
presence of respiratory distress syndrome, broncho-
pulmonary dysplasia, grade III or IV intraventricular
hemorrhage, periventricular leukomalacia, proven
neonatal sepsis, and necrotizing enterocolitis or peri-
natal mortality. The diagnostic criteria of these com-
plications have been previously reported.156 Acute
placental inflammation was diagnosed based on the
presence of inflammatory cells in the chorionic plate,
chorioamniotic membranes (histologic chorioamnio-
nitis),157–159 and/or umbilical cord (funisitis).157,158
Amniocentesis and Amniotic Fluid Processing
Patients with preterm labor and intact membranes
who had transabdominal ultrasound-guided amnio-
centesis to evaluate possible intra-amniotic infection
(within the standard of care at the Detroit Medical
Center) were eligible for the study. AF was immedi-
ately transported in a capped sterile syringe to the
clinical laboratory. Evaluation of white blood cell
(WBC) count, glucose concentration, and Gram
stain of AF was also performed shortly after collec-
tion. AF not required for clinical assessment was
centrifuged for 10 min at 4°C shortly after the
amniocentesis, and the supernatant was aliquoted
and stored at 70°C until analysis. The current
management for preterm labor in our hospital is to
administer corticosteroids (betamethasone or dexa-
methasone) between 24 and 34 weeks of gestation.
Betamethasone is given intramuscularly in two
doses (12 mg), 24 hr apart, and dexamethasone is
administered intramuscularly in 4 doses (6 mg),
12 hr apart.
Detection of Microorganisms with Cultivation and
Molecular Methods
AF was analyzed using cultivation techniques (aero-
bic, anaerobic, and genital mycoplasmas) as well
as with PCR/ESI-MS (Ibis). Briefly, DNA was
extracted from 300 lL of AF using a method that
combines bead-beating cell lysis with a magnetic-
bead-based extraction method.160,161 Extracted DNA
was amplified by the previously described broad bac-
teria and candida (BAC) detection assay according to
the manufacturer’s instructions.162 PCR/ESI-MS can
identify 3400 bacteria and 40 Candida spp, which
are represented in the platform’s signature data-
base.163–165 For viral detection, the nucleic acids
were extracted from 300 lL of AF using a method
that combines chemical lysis with a magnetic-bead-
based extraction method. The extracted RNA/DNA
was amplified on the broad viral assay according to
the manufacturer’s instructions. In the eight wells,
there were 14 primer pairs used to detect the follow-
ing viruses: Herpes simplex virus 1 (HHV-1), Herpes
simplex virus 2 (HHV-2), Varicella-zoster virus (HHV-3),
Epstein-Barr virus (HHV-4), Cytomegalovirus (HHV-5),
Kaposi’s sarcoma-associated herpes virus (HHV-8),
human adenoviruses, human enteroviruses, BK poly-
omavirus, JC polyomavirus, and Parvovirus B19.165
After PCR amplification, 30 lL aliquots of each
PCR product were desalted and analyzed via ESI-MS
as previously described.163,166 The presence of
microorganisms was determined by signal processing
and triangulation analysis of all base composition
signatures obtained from each sample and compared
with a database. The sensitivity [level of detection
(LOD)] of the assay for the detection of bacteria in
blood is on average 100 colony-forming units (CFU)
per mL [95% confidence interval (CI), 6–600 CFU/
mL].164 A comparison of detection limits between
blood and AF shows comparable detection limits
(100 CFU/mL). The sensitivity for the broad viral in
plasma ranges from 400 to 6600 copies/mL.167
Detection limits in AF ranged from ~800 to 1600
copies/mL (depending upon the specific microorgan-
ism).
IL-6 and HMGB1 Concentrations in Amniotic
Fluid
AF concentrations of IL-6 and HMGB1 were deter-
mined by sensitive and specific enzyme immunoas-
says obtained from R&D Systems (Minneapolis, MN,
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USA) and IBL International (Toronto, ON, Canada),
respectively. An initial assay validation was per-
formed in our laboratory prior to conducting this
study. Briefly, the immunoassays utilized a quantita-
tive sandwich enzyme immunoassay technique, and
the concentrations were determined by interpolation
from the standard curves. The inter- and intra-assay
coefficients of variation for IL-6 were 8.7% and
4.6%, and for HMGB1, 3.1% and 4.4%, respec-
tively. The detection limits of the assay for IL-6 and
HMGB1 were 0.09 pg/mL and 0.2 ng/mL, respec-
tively.
Statistical Analysis
The Kolmogorov–Smirnov test and visual plot
inspection were used to assess the normality of con-
tinuous data distributions. A Kruskal–Wallis test and
a two-tailed Mann–Whitney U-test were used to
compare differences of arithmetic variables among
and between the groups. Comparisons of proportions
were performed using chi-square or Fisher’s exact
tests. Differences in the frequency of sterile intra-
amniotic inflammation and microbial-associated
inflammation were examined using McNemar’s test.
A receiver operating characteristic (ROC) curve for
the identification of patients who delivered within
seven days was used to select a cutoff for AF con-
centrations of HMGB1. Kaplan–Meier survival
curves were plotted, and the log-rank test was used
to determine whether there were differences in time
to delivery (censoring observations for patients deliv-
ered for maternal or fetal indications). Logistic and
Cox proportional hazard regression models were fit
to examine magnitudes of association. Spearman’s
correlation was used to assess the relationship
between two continuous variables. A two-tailed
P-value of <0.05 was considered statistically signifi-
cant. The statistical package used was SPSS v.15.0
(SPSS, Chicago, IL, USA).
Results
Prevalence of Sterile and Microbial-Associated
Intra-Amniotic Inflammation
Clinical characteristics are displayed in Table I. The
frequency of sterile intra-amniotic inflammation
was significantly greater than that of microbial-
associated intra-amniotic inflammation [26% (35/
135) versus 11% (15/135) (P = 0.005)] (Fig. 1).
When analysis was restricted to patients who deliv-
ered before 37, 34, 32, and 30 weeks of gestation,
the frequency of sterile intra-amniotic inflamma-
tion was higher than that of microbial-associated
intra-amniotic inflammation in all gestational age
subgroups (P = 0.01, 0.03, 0.02, and 0.02, respec-
tively) (see Fig. 1). The earlier the gestational age
at delivery, the higher the prevalence of both
microbial-associated and sterile intra-amniotic
inflammation.
Clinical Characteristics of Sterile Intra-Amniotic
Inflammation
The median gestational age [interquartile range
(IQR)] at amniocentesis was significantly lower in
patients with sterile and microbial-associated intra-
amniotic inflammation than in women without
intra-amniotic inflammation [25 (IQR: 23–32) and
26 (IQR: 23–32) weeks versus 32 (29–33) weeks,
respectively (each P < 0.001); Table I]. There were
no significant differences in other clinical character-
istics, such as maternal age, race, tobacco use, or cer-
vical dilatation at admission among these three
clinical groups (Table I).
The median (IQR) AF concentrations of IL-6 and
WBC count in patients with sterile intra-amniotic
inflammation were lower than those of patients with
microbial-associated intra-amniotic inflammation
[AF IL-6: 12 (5–21) versus 96 (17–266) ng/mL;
P < 0.001; and WBC count: 3 (1–17) versus 295 (2–
960) cells/mm3; P = 0.02]. There was no significant
difference in the median (IQR) gestational age at
delivery between patients with microbial-associated
intra-amniotic inflammation and those with sterile
intra-amniotic inflammation [26 (24–33) versus 27
(24–32) weeks; P = 0.6]. The prevalence of acute
placental inflammation (acute histologic chorioam-
nionitis and/or funisitis) was similar in patients with
intra-amniotic inflammation with or without detect-
able microorganisms [79% (11/14) versus 61% (19/
31); P = 0.3].
Neonatal morbid events (assessed by composite
neonatal morbidity) were significantly more com-
mon in patients with microbial-associated intra-
amniotic inflammation and sterile intra-amniotic
inflammation than in those without intra-amniotic
inflammation [67% (10/15) and 68% (24/35) versus
11% (9/85); each P < 0.001; see Table I]. Impor-
tantly, there was no significant difference in the
prevalence of neonatal morbid events between
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neonates born to mothers with sterile intra-amniotic
inflammation and those born to mothers with
microbial-associated intra-amniotic inflammation
(P = 1.0).
Amniotic Fluid Concentrations of HMGB1 in
Women with Sterile Intra-Amniotic Inflammation
and the Interval to Delivery
The median (IQR) AF concentration of HMGB1 was
significantly higher in patients with sterile intra-
amniotic inflammation (n = 35) than in those
without intra-amniotic inflammation (n = 85) [7.6
(5.8–10.4) versus 6 (4–7.7) ng/mL; P = 0.007].
Among patients with sterile intra-amniotic inflamma-
tion, those who delivered within 7 days after amnio-
centesis (n = 23) had a significantly higher median
(IQR) AF concentration of HMGB1 than patients who
delivered after 7 days (n = 12) [8.8 (5.9–17.3) versus
6.7 (3.7–8.1) ng/mL; P = 0.03) (Fig. 2)]. A cutoff of
8.55 ng/mL was selected to define an increased AF
HMGB1 concentration upon examining a ROC curve
for the identification of patients who delivered within
7 days of amniocentesis, excluding women with
microbial-associated intra-amniotic inflammation
(Fig. 3). Patients with AF concentrations of HMGB1
at or above this cutoff were fivefold more likely (than
those with concentrations below 8.55 ng/mL) to deli-
ver within 7 days of amniocentesis [adjusted odds
Table I Clinical and Demographic Characteristics of the Study Population
No intra-amniotic
inflammation
(n = 85)
Microbial-associated
intra-amniotic inflammation
(n = 15)
Sterile intra-amniotic
inflammation
(n = 35) P-value
Maternal age (years) 23 (20–26) 24 (20–30) 23 (20–26.2) 0.8
BMI (kg/m2) 23 (20–29) 27 (23–29) 23 (20–32) 0.1
Nulliparity 32% (27) 73% (11) 40% (14) 0.009
Race
African-American 89% (76) 73% (11) 91% (30) 0.1
Caucasian 6% (5) 20% (3) 6% (2)
Hispanic 0 7% (1) 3% (1)
Others 5% (4) 0 0
Tobacco use during pregnancy 20% (17) 13% (2) 21% (7) 0.8
Cervical dilatation at admission (cms) 3 (2–4) 4 (2–4) 3 (2–4) 0.1
Gestational age at amniocentesis (weeks) 32 (29–33) 26 (23–32) 25 (23–32) <0.001*
AF white blood cells count (cells/mm3) 1 (0–5) 295 (2–960) 3 (1–17) <0.001*
AF glucose (mg/dL) 29 (24–34) 11 (10–20) 22 (18–28) <0.001*
AF interleukin-6 (ng/mL) 0.8 (0.5–1.1) 96 (17–266) 12 (5–21) <0.001*
Gestational age at delivery (weeks) 36 (34–38) 26 (24–33) 27 (24–32) <0.001*
Composite neonatal morbidity 11% (9) 67% (10) 68% (24) <0.001
Acute placental inflammationa 22.5% (18/80) 79% (11/14) 61% (19/31) <0.001*
Acute histologic chorioamnionitis 21% (17/80) 79% (11/14) 58% (18/31)
Funisitis 13% (10/80) 57% (8/14) 29% (9/31)
Data presented as median (interquartile) and percentage and (n); AF: amniotic fluid; BMI: body mass index.
aAcute placental inflammation was calculated over a total of 125 specimens.
*Kruskal–Wallis test.
Fig. 1 Frequency of sterile and microbial-associated intra-amniotic
inflammation in patients with preterm labor and intact membranes as
a function of the gestational age at delivery. The frequency of sterile
intra-amniotic inflammation was significantly greater than that of
microbial-associated intra-amniotic inflammation [26% (35/135) versus
11% (15/135) (P = 0.005)].
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ratio (OR): 5.1; 95% CI 1.6–15.5], adjusting for gesta-
tional age at amniocentesis and cervical dilatation
with logistic regression.
The amniocentesis-to-delivery interval of women
with sterile intra-amniotic inflammation who had
AF HMGB1 concentrations ≥8.55 ng/mL was signifi-
cantly shorter than that of women with sterile
intra-amniotic inflammation who had AF HMGB1
concentrations below 8.55 ng/mL and women
without intra-amniotic inflammation [median 3,
IQR: 1–7 days versus median 8, IQR: 4–18 days,
and median 31, IQR: 20–59 days (P = 0.02 and
P < 0.0001, respectively, Fig. 4)]. Importantly, there
was no significant difference in the amniocentesis-
to-delivery interval between patients with sterile
intra-amniotic inflammation and AF HMGB1
≥ 8.55 ng/mL compared with patients with micro-
bial-associated intra-amniotic inflammation [median
3, IQR: 1–7 days versus median 1, IQR: 0–8 days;
P = 0.6, Fig. 4)].
Multivariable survival analysis (Cox proportional
hazard modeling) was used to explore the amnio-
centesis-to-delivery interval among different clinical
groups taking into account microbial invasion,
intra-amniotic inflammation, and AF concentration
of HMGB1 while adjusting for cervical dilatation
at admission and gestational age at amniocentesis.
Patients with either microbial-associated or sterile
intra-amniotic inflammation with AF HMG
B1 ≥ 8.55 ng/mL had a shorter amniocentesis-to-
delivery interval than those without intra-amniotic
inflammation [hazard ratio of 14.6 (95% CI, 6.2–
34), and 17.7 (95% CI, 7.3–42), respectively].
Moreover, patients with sterile intra-amniotic
inflammation and AF HMGB1 < 8.55 ng/mL also
had a shorter amniocentesis-to-delivery interval
than those without intra-amniotic inflammation
[hazard ratio of 6.5 (95% CI%, 3.2–13.3)].
There was an association between AF HMGB1
concentrations and acute inflammatory lesions in
the placenta (acute histologic chorioamnionitis and/
or funisitis). The median (IQR) AF concentration of
HMGB1 was significantly higher in patients with
acute placental inflammation (n = 48) than that of
patients without these lesions (n = 77) [8.5 (5.1–
17.8) versus 6.6 (4.7–8.3) ng/mL; P = 0.009]. The
prevalence of acute placental inflammation was sig-
nificantly higher in patients with increased AF
HMGB1 (> 8.55 ng/mL) than in those with a low
AF concentration of HMGB1 [58% (24/41) versus
29% (24/84); P = 0.001].
Fig. 2 AF concentrations of HMGB1 in patients with sterile intra-
amniotic inflammation according to whether delivery occurred within
or after 7 days of amniocentesis. Patients who delivered within
7 days after amniocentesis had a significantly higher median (IQR) AF
concentration of HMGB1 than patients who delivered after 7 days [8.8
(5.9–17.3) versus 6.7 (3.7–8.1); P = 0.03].
Fig. 3 Receiver operator characteristic curve analysis of AF
concentrations of HMGB1 for the identification of patients without
microbial-associated intra-amniotic inflammation who subsequently
delivered within 7 days after amniocentesis. AF HMGB1 concentration
of 8.55 ng/mL had an area under the ROC curve of 0.67 (95% CI 0.55–
0.78; P = 0.005), a sensitivity of 46% (16/35), a specificity of 84% (71/
85), a positive predictive value of 53% (16/30), and a negative
predictive value of 80% (71/90) for the identification of patients who
subsequently delivered within 7 days.
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Amniotic Fluid Concentrations of IL-6 in Patients
with Sterile Intra-Amniotic Inflammation and
Increased HMGB1 Concentrations
Fig. 5 displays AF IL-6 concentrations in patients
with sterile intra-amniotic inflammation according
to the AF concentration of HMGB1 [below 8.55 ng/
mL; (n = 20) and above 8.55 ng/mL; (n = 15)].
The median (IQR) AF concentration of IL-6 was
significantly higher in patients with AF HM
GB1 ≥ 8.55 ng/mL compared with those with AF
HMGB1 < 8.55 ng/mL [21 (10–27) versus 7 (3.5–
15.3) ng/mL; P = 0.006; Fig. 5]. AF concentrations
of HMGB1 were moderately correlated with AF IL-6
concentrations (Spearman’s Rho 0.6; P < 0.001) and
inversely correlated with the interval from amnio-
centesis to delivery (Spearman’s Rho -0.4; P = 0.03)
in patients with sterile intra-amniotic inflammation.
Antibiotics were administered in 29% (39/135) of
patients before amniocentesis. Most patients [60%
(81/135)] did not receive corticosteroids before
amniocentesis. We repeated the analysis adjusting
for the administration of antibiotics (within 6 hr)
and corticosteroids (within 7 days) before amniocen-
tesis using analysis of covariance, and the results of
amniotic fluid IL-6 and HMGB1 concentrations
remained significant among groups.
Discussion
Principal Findings of the Study
(i) Sterile intra-amniotic inflammation is more
common than microbial-associated intra-amniotic
inflammation in patients with preterm labor and
intact membranes; (ii) patients with sterile intra-
amniotic inflammation had early preterm deliveries
at a comparable gestational age to women with
microbial-associated intra-amniotic inflammation;
(iii) the AF glucose concentration and WBC count in
Fig. 4 Survival analysis of amniocentesis-to-delivery interval (days)
according to the presence of microbial-associated intra-amniotic
inflammation or sterile intra-amniotic inflammation with the presence
of higher concentration of alarmins. Patients in whom labor was
induced were censored and are represented by crosses. The
amniocentesis-to-delivery interval among women with sterile intra-
amniotic inflammation who had increased AF HMGB1 concentrations
(≥8.55 ng/mL) was significantly shorter than that of (i) women with
sterile intra-amniotic inflammation who had AF HMGB1 concentrations
below 8.55 ng/mL and (ii) women without intra-amniotic inflammation
[median 3, IQR: 1–7 days versus median 8, IQR: 4–18 days and
median 31, IQR: 20–59 days (P = 0.02 and P < 0.0001), respectively].
There was no significant difference in the amniocentesis-to-delivery
interval between patients with sterile intra-amniotic inflammation and
AF HMGB1 concentrations ≥ 8.55 ng/mL and those with microbial-
associated intra-amniotic inflammation.
Fig. 5 AF concentrations of IL-6 in patients with sterile intra-amniotic
inflammation according to the AF concentration of HMGB1 (above or
below 8.55 ng/mL). The median (IQR) AF concentration of IL-6 was
significantly higher in patients with AF HMGB1 ≥ 8.55 ng/mL than in
those with AF HMGB1 < 8.55 ng/mL [21 (10–27) versus 7 (3.5–15.3)
ng/mL; P = 0.006].
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cases of sterile intra-amniotic inflammation were
within normal ranges; (iv) acute histologic chorio-
amnionitis and/or funisitis were identified in patients
with sterile intra-amniotic inflammation, as well as
in those with microbial-associated intra-amniotic
inflammation; (v) the intensity of the inflammatory
response (assessed by AF IL-6 concentrations) was
stronger in patients with microbial-associated intra-
amniotic inflammation than in patients with sterile
intra-amniotic inflammation; and (vi) patients with
sterile intra-amniotic inflammation and high AF
concentrations of HMGB1 delivered earlier than
those with low AF concentrations of HMGB1. This is
compelling evidence that sterile intra-amniotic
inflammation is of major importance in preterm
parturition.
Sterile versus Microbial-Associated Intra-Amniotic
Inflammation
The key finding of this study is that in patients
with preterm labor and intact membranes, sterile
intra-amniotic inflammation is more common than
microbial-associated intra-amniotic inflammation.
We have previously proposed that intra-amniotic
inflammation without detectable microorganisms
is a mechanism of disease in preterm
labor71,72,74,76,125–129,131,168 based on observations
of increased AF concentrations of inflammatory
mediators [IL-6,71,72,74,91,96,168–175 IL-8,106 matrix
metalloproteinase 8 (MMP-8)76,128, monocyte che-
motactic protein-1 (MCP-1),113,176 and other
inflammatory markers79,80,107,172,177] in the absence
of detectable microorganisms. The designation of
‘sterile intra-amniotic inflammation’ depends on
the techniques employed to exclude the presence
of microbes. In this study, we used a new sensi-
tive method which uses electrospray ionization
mass spectrometry (ESI-MS) for base composition
analysis of polymerase chain reaction (PCR) prod-
ucts to rapidly create a signature that allows for
the identification of a large number of microorgan-
isms (bacteria and viruses) at the genus and spe-
cies level within 8 hr. Therefore, the classification
of intra-amniotic inflammation as ‘sterile’ was
determined with a high degree of confidence. It is
possible that future technological advances will
allow discovery of microorganisms, which have
escaped detection. The use of next-generation
sequencing may result in the detection of low
quantities of microbial nucleic acids in biological
fluids. Yet, determining whether this reflects the
true presence of bacteria and viruses (rather than
contamination) is a challenge.
Clinical and Laboratory Characteristics of Sterile
Intra-Amniotic Inflammation
Although the clinical characteristics of patients with
sterile intra-amniotic inflammation were similar to
those with microbial-associated intra-amniotic infla-
mmation (e.g., gestational age at presentation, short
interval to delivery, and a high rate of adverse
neonatal events), the laboratory findings were differ-
ent. Specifically, the AF WBC count and AF glucose
concentrations of patients with sterile intra-amniotic
inflammation were within normal range (see
Table I). Therefore, a work-up based on AF WBC
count and AF glucose concentration would fail to
identify the most common type of intra-amniotic
inflammation in patients with preterm labor and
intact membranes. Interestingly, the AF concentra-
tions of IL-6 are significantly lower in patients with
sterile intra-amniotic inflammation than in those
with microbial-associated intra-amniotic inflamma-
tion. Further studies are required to characterize the
behavior of the cytokine–chemokine network in
amniotic fluid and maternal blood in patients with
sterile intra-amniotic inflammation.
Acute Histologic Chorioamnionitis Can Occur in
the Absence Of Microbial-Associated Intra-
Amniotic Inflammation
Acute histologic chorioamnionitis and funisitis are
generally considered to be due to amniotic fluid
infection.91,95,170,178–187 Early studies using amnio-
centesis in patients with spontaneous preterm labor
who delivered within 48 hr showed that 71% (27/
38) of patients with acute histologic chorioamnioni-
tis and 81% (29/36) with funisitis had positive AF
cultures for bacteria.188 Hillier et al.92 reported that
in 73% (16/22) of placentas with acute histologic
chorioamnionitis, bacteria could be isolated from the
chorioamniotic space. The findings reported herein
indicate that 58% (n = 18/31) of patients with sterile
intra-amniotic inflammation have acute histologic
chorioamnionitis and that of all patients with acute
histologic chorioamnionitis, 38% (n = 18/48) had
sterile intra-amniotic inflammation at the time of
amniocentesis. We propose that DAMPs-induced
inflammation occurs after a danger signal engages a
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pattern recognition receptor (PRR), such as toll-like
receptors (TLRs)-2, -4, and -9, leading to the release
of HMGB1 and other alarmins that can induce
inflammation by stimulating the production of
inflammatory cytokines such as IL-6, IL-1b, IL-8,
and TNF-a.144,145,189,190
Although our observations suggest that MIAC was
not present at the time of amniocentesis in patients
with sterile intra-amniotic inflammation who subse-
quently delivered and had acute histologic chorio-
amnionitis, it is possible that microorganisms may
have invaded the amniotic cavity at some point
before the procedure and induced intra-amniotic
inflammation, which eradicated the microbes. This
possibility is extremely difficult to exclude in
humans. It is also possible that danger-associated
intra-amniotic inflammation led to preterm labor
and that a secondary MIAC occurred, which was
not detected at the time of amniocentesis. Studies
in which placentas and membranes are examined
for microorganisms using culture, sequence-based
techniques, and morphologic approaches are
required to address this possibility. The biology of
infection during pregnancy is extremely complex.
Recent observations in animal models suggest that
systemic and localized infections in the lower geni-
tal tract during pregnancy may increase the suscep-
tibility to microbial products (i.e., endotoxin) or
bacteria (two-hit hypothesis model).191–195 Whether
this is the case in humans remains to be deter-
mined.
Danger Signals in Patients with Sterile Intra-
Amniotic Inflammation and Preterm Labor
Inflammation is a mechanism of host defense in
response to infection- and non-infection-related
insults.196–200 The innate immune system initiates
an inflammatory response when PRRs sense exoge-
nous or endogenous signals considered potentially
harmful to the host.146,196,199–213 During infection,
these signals include molecular structures that are
conserved among microbial species, known as patho-
gen-associated molecular patterns (PAMPs).203,207,214
Tissue damaged from non-infectious origins (e.g.
trauma, ischaemia-reperfusion injury, urate crystals,
chemical injuries, etc.) induce the release alarmins
or ‘danger signals’,154,203,207,214 known as DAMPs.
When recognized by PRRs, these multifunctional
proteins are also capable of inducing an inflamma-
tory response.139,144,145,189,207,212,215
In this study, AF concentrations of HMGB1, a pro-
totypical ‘alarmin’, were significantly higher in
patients with sterile intra-amniotic inflammation
than in patients without intra-amniotic inflamma-
tion. In addition, we report that patients with sterile
intra-amniotic inflammation and high AF concentra-
tions of HMGB1 (≥ 8.55 ng/mL) had a significantly
shorter amniocentesis-to-delivery interval than
patients with AF HMGB1 < 8.55 ng/mL. These find-
ings suggest that alarmins can play a role in preterm
labor in the setting of sterile intra-amniotic inflam-
mation.
HMGB1 is a chromatin component located in the
nucleus of eukaryotic cells, whose functional role is
to inform other cells that damage has
occurred.133,135,149,189,216–218 This protein has chem-
otactic activity for monocytes,152,153,217,219,220 mac-
rophages,221,222 neutrophils,221–224 and dendritic
cells.137,138,217,225,226 HMGB1 is released into the
extracellular space either actively or passively. Active
secretion occurs from stressed cells of the immune
system (e.g., macrophages, monocytes and cells at
the frontline of host defense).133,135,137,145,149 Passive
release occurs during sterile cell injury and is almost
immediate.147 During infection, HMGB1 is trans-
ferred from the nucleus of monocytes, macrophages,
and other immune cells to the cytosol, where it
accumulates in intracellular vesicles prior to secre-
tion, which takes approximately 8 hr.147,153,227 In
mice, serum concentrations of HMGB1 increase 8 to
32 hr after endotoxin exposure; thus, HMGB1 has
been considered a ‘late’ mediator of inflamma-
tion.227–230 Alarmins are potential therapeutic tar-
gets. Blocking HMGB1 with neutralizing antibodies
reduces mortality in animal models of endotox-
emia227,230 and sepsis;228,231 this has generated
considerable interest in HMGB1 as a potential phar-
macologic target in sepsis and sterile inflammation.
Evidence that ‘alarmins’ Can Induce Preterm Labor
Systemic administration of IL-1a has been shown to
induce preterm delivery in mice,232,233 an effect that
was abrogated by pre-treatment with the IL-1 recep-
tor antagonist.233 Subsequently, Bry et al.234
reported that intra-amniotic injection of IL-1a in
rabbits similarly induces preterm labor. Increased AF
concentrations of other alarmins have been reported
in women with preterm labor with intact mem-
branes or preterm pre-labor rupture of membranes,
including S100B,125 HMGB1,129,131 and heat-shock
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proteins.126,127 Whether these multifunctional pro-
teins can induce preterm labor and delivery remains
to be determined. Further studies of the effect of
HMGB1 on the chorioamniotic membranes and
pregnancy are required.
Although we have reported that HMGB1 concen-
trations are increased in a subset of patients with
preterm labor,129 the mechanisms whereby HMGB1
may lead to the onset of labor are unknown. Addi-
tional research is required to answer these ques-
tions. Necrotic or stress cells can release alarmins
including HMGB1. These alarmins would be
responsible, at least in part, for inducing inflamma-
tion and the onset of labor. The effect of IL-1a in
inducing parturition232–234 may be mediated
through the activation of the components of the in-
flammasome.235–237
Conclusion
(i) Sterile intra-amniotic inflammation is more fre-
quent than microbial-associated inflammation in
patients with preterm labor and intact membranes,
(ii) we propose that danger signals participate in
sterile intra-amniotic inflammation in the setting of
preterm labor with intact membranes, and (iii)
future research on the mechanisms responsible for
sterile intra-amniotic inflammation, biomarkers, and
therapeutic interventions is required to address the
challenges offered by this clinical condition.
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